Dovitinib Dilactic Acid
CAS No. 852433-84-2
Dovitinib Dilactic Acid ( Dovitinib Dilactic acid; TKI258 Dilactic acid; CHIR-258, TKI258 )
Catalog No. M17618 CAS No. 852433-84-2
Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 68 | Get Quote |
|
10MG | 103 | Get Quote |
|
25MG | 211 | Get Quote |
|
50MG | 365 | Get Quote |
|
100MG | 583 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDovitinib Dilactic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
-
DescriptionDovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.
-
SynonymsDovitinib Dilactic acid; TKI258 Dilactic acid; CHIR-258, TKI258
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
Recptorc-Kit; FGFR1; FGFR3; FLT3; VEGFR3/FLT4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number852433-84-2
-
Formula Weight572.59
-
Molecular FormulaC21H21FN6O·2C3H6O3
-
Purity98%
-
Solubility——
-
SMILESCC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C/4\C(=C5C(=NC4=O)C=CC=C5F)N)/N3
-
Chemical Name2-Hydroxypropanoic acid compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1- piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Trudel S, et al. Blood. 2005, 105(7), 2941-2948.
molnova catalog
related products
-
Methotrexate disodiu...
Methotrexate disodium is an tetrahydrofolate dehydrogenase inhibitor.
-
DHODH-IN-11
DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03.A compound structurally related to leflunomide was designed, which contained furan ring (compound 14a).
-
CM 10
CM 10 is an aldehyde dehydrogenase 1A family(ALDH1A) inhibitor.